Efficient tumor regression induced by genetically engineered tumor cells secreting interleukin-2 and membrane-expressing allogeneic MHC class I antigen

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 1, 2001, Pages 27-33

  Qian, Shu Bing ^a   Li, Yu ^a   Qian, Guan Xiang ^a   Chen, Shi Shu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Allogeneic MHC class I; Co expression; Hepatoma; Interleukin 2; Poly cistronic vector

Indexed keywords

INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; GENETIC ENGINEERING; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CANCER TRANSPLANTATION; CELL CULTURE; CELL SEPARATION; FLOW CYTOMETRY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; NEOPLASM; PLASMID; RETROVIRUS; RIBOSOME; SECRETION; TIME; WESTERN BLOTTING; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; EXPERIMENTAL NEOPLASM; IMMUNOSTIMULATION; IMMUNOTHERAPY; TUMOR IMMUNITY; TUMOR REGRESSION;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL SEPARATION; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2; LIVER NEOPLASMS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; MODELS, GENETIC; NEOPLASM TRANSPLANTATION; NEOPLASMS; PLASMIDS; RETROVIRIDAE; RIBOSOMES; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034744321     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320000176     Document Type: Article

References (33)

1. Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions
2. Murine tumor cells transduced with the gene for TNF-α. Evidence for paracrine immune effects of TNF against tumors
3. Human tumor antigens recognized by T lymphocytes
4. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage clone stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
5. Direst transfer of a foreign MHC gene into human melanoma alters T cell receptor Vβ usage by tumor-infiltrating lymphocytes
6. Interleukin-2 production by tumor cells bypass T helper function in generation of an antitumor response
7. Retroviral vector-mediated γ-1FN gene transfer into tumor cells generates potent and long-lasting antitumor immunity
8. IL-2 gene transfer abrogates tumorigenicity and induces protective immunity
9. Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2 K genes
10. Immunotherapy of cancer using cytokine gene-modified tumor vaccines
11. Treatment of established renal cancer by tumor cells engineered to secrete IL-4
12. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
13. Rejection of transplantable AKR leukemia cells following MHC DNA-mediated cell transformation
14. Tumor rejection by transfection with allogeneic class I histocompatibility gene
15. Eradication of tumor growth via biolistic transformation with allogeneic MHC genes
16. Requirement of recognition of class II molecules and processed tumor antigen for optimal generation of synergeneic tumor-specific class I-restricted CTL
17. H-2 K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients
18. Retroviral vectors containing putative internal ribosome entry sites: Development of a polycistronic gene transfer system and application to human gene therapy
19. Cytokines, tumor-cell death and immunogenicity: A question of choice
20. Clinical protocol: Immunotherapy of cancer by direct gene transfer into tumors
21. Combination gene transfer to potentiate tumor regression
22. Cancer vaccines: A road map for the next decade
23. Immunological approach to gene therapy of human cancer: Improvements through the understanding of mechanism(s)
24. Anti-metastattc vaccination of tumorbearing mice with two types of gamma-interferon gene inserted tumor cells
25. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases
26. Enhanced expression of HLA class I molecules in human hepatocellular carcinoma cells transduced with γ-interferon gene
27. Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferonγ cDNAs
28. Transloading of tumor cells with foreign major histocompatibility complex class I peptide ligand: A novel general strategy for the generation of potent cancer vaccines
29. Indirect presentation of MHC antigens in transplantation
30. Interleukin-2
31. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector
32. Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells
33. Experimental and clinical studies of cytokine gene-modified tumor cells